Balance Sheet

v3.24.2.u1

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 573,171	$ 574,962
Accounts receivable, net	38,651	54,605
Inventory	49,294	51,397
Prepaid expenses and other current assets	17,063	17,830
Interest rate cap	6,575	0
Government funding receivable	608	1,118
Total current assets	685,362	699,912
Property and equipment, net	165,503	162,900
Goodwill	326,029	326,029
Intangible assets, net	207,249	220,987
Other assets	63,465	77,622
Total assets	1,447,608	1,487,450
Current liabilities:
Accrued expenses and other current liabilities	40,719	60,237
Deferred revenue	2,078	3,360
Current portion of long-term debt	5,440	5,440
Current portion of finance lease liabilities	710	633
Total current liabilities	68,552	87,468
Long-term debt, less current portion	517,083	518,707
Finance lease liabilities, less current portion	31,527	31,897
Other long-term liabilities	54,032	59,494
Total liabilities	671,194	697,566
Commitments and contingencies (Note 6)
Stockholders’ equity:
Additional paid-in capital	168,337	128,503
Retained earnings	266,074	285,737
Total stockholders’ equity attributable to Maravai LifeSciences Holdings, Inc.	436,933	416,753
Non-controlling interest	339,481	373,131
Total stockholders’ equity	776,414	789,884
Total liabilities and stockholders’ equity	1,447,608	1,487,450
Class A Common Stock
Stockholders’ equity:
Common stock	1,415	1,322
Class B Common Stock
Stockholders’ equity:
Common stock	1,107	1,191
Nonrelated Party
Current liabilities:
Accounts payable	12,536	10,729
Related Party
Current liabilities:
Accounts payable	$ 7,069	$ 7,069

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Source